We treated 40 children, aged between 15 d and 17 y, diagnosed with acu
te respiratory distress syndrome and/or pulmonary hypertension, with i
nhaled nitric oxide. The most frequent underlying diagnosis associated
with ARDS were bronchopneumonia (eight), cardiac surgery (five), and
sepsis (three). Pulmonary hyper tension was secondary to cardiomyopath
y in 2 patients and occurred in the postoperative period of cardiac su
rgery in 17 patients-the most frequent were ventricular septal defect
(5), transposition of great arteries (4), and atrioventricular septal
defect (3). In 11 patients, sudden discontinuation of nitric oxide ind
uced a decrease in oxygenation associated in some of the patients with
an increase in pulmonary artery pressure. In two patients discontinua
tion of nitric oxide induced severe pulmonary hypertension, extreme br
adycardia and hypoxaemia, which required cardiopulmonary resuscitation
. When exogenous nitric oxide is abruptly interrupted, hypoxaemia and
pulmonary hypertension are found in some patients, due to a decrease i
n the nitric oxide concentration in the pulmonary circulation. This ma
y be caused by the exogenous nitric oxide administration that may have
inhibited endogenous production. We recommend making a progressive wi
thdrawal of inhaled nitric oxide to avoid the side effects observed in
the sudden discontinuation.